PROCEPT BioRobotics Corp
corporate_fare Company Profile
PROCEPT BioRobotics Corp (NASDAQ:PRCT) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 16 items for PRCT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 7/10. Across its 16 most recent items scored 7 or higher, the top rating is 8/10, with 9 rated 8 or above. Recent SEC coverage for PRCT spans 10-Q, 8-K, DEF 14A, 4.
Recent high-impact activity:
- PROCEPT 10-Q: Q3 Revenue $98.3M Misses, Cash Burn Widens, Two Lawsuits Disclosed
- Q3 Revenue Misses Estimates as Adjusted EBITDA Loss Widens to $9.8M
- PROCEPT BioRobotics Posts 19% Revenue Growth in Q2, Lifts Procedure Guidance
- Securities Fraud Class Action Filed Against PROCEPT BioRobotics Over Alleged Discount Program
- PROCEPT Slashes Guidance as Handpiece Sales Plunge 30%
Financial Snapshot
Short Interest & Short Volume
9.02 days to coverFINRA reported short interest of 7,858,235 shares in PRCT as of the October 30, 2026 settlement, a 4.8% increase from the prior period — about 9.0 days to cover at its recent average daily volume. On November 20, 2026, 59.0% of PRCT volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.